170
Participants
Start Date
November 30, 2016
Primary Completion Date
May 22, 2018
Study Completion Date
May 22, 2018
AliveCor handheld mobile ECG
"Specific Aim 1: independent risk factors for methadone-associated QTc interval prolongation will be determined through retrospective analysis of electronic medical records of methadone-treated patients in a narcotic treatment center. Patients will be asked to come to the Narcotic Treatment Center for one 12-lead ECG~Specific Aim 2: QTc intervals from ECGs generated by the AliveCor® heart monitor will be compared prospectively to simultaneous twelve lead ECGs for validation purposes in the methadone-treated patients in a narcotic treatment center."
Eskenazi Health, Indianapolis
Purdue University
OTHER
Indiana University
OTHER